DB19234InvestigationalProtein Based Therapies
Atexakin alfa is under investigation in clinical trial NCT05435742 (SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)).
- Also known as
- Recombinant interleukin 6
- Code names
- SON-080
Resolves to
Compound
What you can answer from here — as of July 10, 2024
Which companies are running trials of Atexakin alfa, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account